K.A. Bennett

2.9k total citations · 1 hit paper
18 papers, 2.2k citations indexed

About

K.A. Bennett is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, K.A. Bennett has authored 18 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Cellular and Molecular Neuroscience and 5 papers in Physiology. Recurrent topics in K.A. Bennett's work include Receptor Mechanisms and Signaling (12 papers), Neuropeptides and Animal Physiology (7 papers) and Adenosine and Purinergic Signaling (5 papers). K.A. Bennett is often cited by papers focused on Receptor Mechanisms and Signaling (12 papers), Neuropeptides and Animal Physiology (7 papers) and Adenosine and Purinergic Signaling (5 papers). K.A. Bennett collaborates with scholars based in United Kingdom, Italy and United States. K.A. Bennett's co-authors include Christopher G. Tate, Guillaume Lebon, Christopher J. Langmead, Fiona H. Marshall, Tony Warne, Patricia C. Edwards, Andrew G. W. Leslie, A.S. Dore, James C. Errey and Ali Jazayeri and has published in prestigious journals such as Nature, Journal of Molecular Biology and Journal of Medicinal Chemistry.

In The Last Decade

K.A. Bennett

18 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation

2011 700 citations Guillaume Lebon, Tony Warne et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K.A. Bennett United Kingdom	13	1.9k	1.1k	490	361	253	18	2.2k
David M. Thal Australia	22	2.2k 1.1×	1.1k 1.0×	243 0.5×	313 0.9×	250 1.0×	41	2.5k
Karen J. Gregory Australia	33	2.6k 1.3×	2.0k 1.8×	209 0.4×	188 0.5×	257 1.0×	78	3.0k
Céline Valant Australia	29	3.0k 1.6×	1.9k 1.7×	282 0.6×	393 1.1×	521 2.1×	70	3.4k
Byron Carpenter United Kingdom	12	1.4k 0.7×	728 0.6×	233 0.5×	242 0.7×	79 0.3×	19	1.6k
Ali Jazayeri United Kingdom	17	1.7k 0.9×	987 0.9×	88 0.2×	394 1.1×	276 1.1×	28	2.0k
Katie Leach Australia	24	2.4k 1.2×	1.5k 1.3×	104 0.2×	186 0.5×	241 1.0×	56	3.0k
Sebastian Lazareno United Kingdom	27	2.5k 1.3×	1.8k 1.6×	125 0.3×	183 0.5×	141 0.6×	55	2.9k
John D. Pediani United Kingdom	29	1.5k 0.8×	974 0.9×	135 0.3×	196 0.5×	52 0.2×	65	2.2k
Cornelius Krasel Germany	27	2.2k 1.2×	1.5k 1.4×	73 0.1×	169 0.5×	93 0.4×	50	2.6k
Vignir Ísberg Denmark	14	1.2k 0.6×	702 0.6×	45 0.1×	216 0.6×	230 0.9×	19	1.4k

Countries citing papers authored by K.A. Bennett

Since Specialization

Citations

This map shows the geographic impact of K.A. Bennett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.A. Bennett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.A. Bennett more than expected).

Fields of papers citing papers by K.A. Bennett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K.A. Bennett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.A. Bennett. The network helps show where K.A. Bennett may publish in the future.

Co-authorship network of co-authors of K.A. Bennett

This figure shows the co-authorship network connecting the top 25 collaborators of K.A. Bennett. A scholar is included among the top collaborators of K.A. Bennett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K.A. Bennett. K.A. Bennett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Regazzo, Daniela, Cliona MacSweeney, Eugenia Sergeev, et al.. (2023). A novel somatostatin receptor ligand for human ACTH – and GH –secreting pituitary adenomas. European Journal of Endocrinology. 190(1). K8–K16. 3 indexed citations

Bakker, Geor, et al.. (2022). Targeting the Type 5 Metabotropic Glutamate Receptor: A Potential Therapeutic Strategy for Neurodegenerative Diseases?. Frontiers in Pharmacology. 13. 893422–893422. 20 indexed citations

Sergeev, Eugenia, et al.. (2022). Effect of HTL0045725, a selective agonist of the orphan receptor GPR52, on kinase and transcription factor phosphorylation in striatal neurons. Neuroscience Applied. 1. 100412–100412. 2 indexed citations

Brighton, Cheryl A., Jason Brown, Richard F. Mould, et al.. (2021). Characterisation of inverse agonism of the orphan-G protein-coupled receptor GPR52 by cannabinoid ligands Cannabidiol and O-1918. Heliyon. 7(6). e07201–e07201. 6 indexed citations

Bennett, K.A., Eugenia Sergeev, Cliona MacSweeney, Geor Bakker, & Anne Cooper. (2021). Understanding Exposure-Receptor Occupancy Relationships for Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators across a Range of Preclinical and Clinical Studies. Journal of Pharmacology and Experimental Therapeutics. 377(1). 157–168. 3 indexed citations

Jenkins, Laura, Sara Marsango, Sarah J. Mancini, et al.. (2021). Discovery and Characterization of Novel Antagonists of the Proinflammatory Orphan Receptor GPR84. ACS Pharmacology & Translational Science. 4(5). 1598–1613. 16 indexed citations

Bennett, K.A., J.A. Christopher, & Benjamin G. Tehan. (2020). Structure-based discovery and development of metabotropic glutamate receptor 5 negative allosteric modulators. Advances in pharmacology. 88. 35–58. 7 indexed citations

Rappas, Mathieu, A. Ali, K.A. Bennett, et al.. (2019). Comparison of Orexin 1 and Orexin 2 Ligand Binding Modes Using X-ray Crystallography and Computational Analysis. Journal of Medicinal Chemistry. 63(4). 1528–1543. 54 indexed citations

Oswald, Christine, Mathieu Rappas, James Kean, et al.. (2016). Intracellular allosteric antagonism of the CCR9 receptor. Nature. 540(7633). 462–465. 196 indexed citations

10.

Christopher, J.A., K.A. Bennett, A.S. Dore, et al.. (2015). Fragment and Structure-Based Drug Discovery for a Class C GPCR: Discovery of the mGlu ₅ Negative Allosteric Modulator HTL14242 (3-Chloro-5-[6-(5-fluoropyridin-2-yl)pyrimidin-4-yl]benzonitrile). Journal of Medicinal Chemistry. 58(16). 6653–6664. 122 indexed citations

11.

Dore, A.S., Krzysztof Okrasa, Jayesh C. Patel, et al.. (2014). Structure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain. Nature. 511(7511). 557–562. 324 indexed citations

12.

Bennett, K.A., A.S. Dore, J.A. Christopher, Dahlia R. Weiss, & Fiona H. Marshall. (2014). Structures of mGluRs shed light on the challenges of drug development of allosteric modulators. Current Opinion in Pharmacology. 20. 1–7. 26 indexed citations

13.

Bennett, K.A., Benjamin G. Tehan, Guillaume Lebon, et al.. (2013). Pharmacology and Structure of Isolated Conformations of the Adenosine A2A Receptor Define Ligand Efficacy. Molecular Pharmacology. 83(5). 949–958. 58 indexed citations

14.

Dore, A.S., N.J. Robertson, James C. Errey, et al.. (2011). Structure of the Adenosine A2A Receptor in Complex with ZM241385 and the Xanthines XAC and Caffeine. Structure. 19(9). 1283–1293. 453 indexed citations

15.

Lebon, Guillaume, K.A. Bennett, Ali Jazayeri, & Christopher G. Tate. (2011). Thermostabilisation of an Agonist-Bound Conformation of the Human Adenosine A2A Receptor. Journal of Molecular Biology. 409(3). 298–310. 103 indexed citations

16.

Lebon, Guillaume, Tony Warne, Patricia C. Edwards, et al.. (2011). Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation. Nature. 474(7352). 521–525. 700 indexed citations breakdown →

17.

Smith, Nicola J., K.A. Bennett, & Graeme Milligan. (2010). When simple agonism is not enough: Emerging modalities of GPCR ligands. Molecular and Cellular Endocrinology. 331(2). 241–247. 56 indexed citations

18.

Bennett, K.A., Christopher J. Langmead, Alan Wise, & Graeme Milligan. (2009). Growth Hormone Secretagogues and Growth Hormone Releasing Peptides Act As Orthosteric Super-Agonists but Not Allosteric Regulators for Activation of the G Protein Gαo1 by the Ghrelin Receptor. Molecular Pharmacology. 76(4). 802–811. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact